Product Number |
OAAB04897 |
Product Page |
www.avivasysbio.com/vars-antibody-n-terminal-region-oaab04897.html |
Name |
VARS Antibody - N-terminal region (OAAB04897) |
Molecular Weight |
140476 Da |
Isotype |
Rabbit Ig |
NCBI Gene Id |
7407 |
Host |
Rabbit |
Clonality |
Polyclonal |
Concentration |
Approximately 0.5mg/ml. Actual concentration varies with each lot. |
Alias Symbols |
G7A, VARS, VARS2, NDMSCA |
Product Format |
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS. |
Reconstitution and Storage |
Maintain refrigerated at 2-8C for up to 2 weeks. For long term storage store at -20C in small aliquots to prevent freeze-thaw cycles. |
Datasheets/Manuals |
Printable datasheet for anti-VARS antibody - OAAB04897 |
Application Info |
WB: 1:1000 IHC-P: 1:10~50 |
Immunogen |
This VARS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 251-279 amino acids from the N-terminal region of human VARS. |
Additional Information |
Description: This VARS antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 258~287 amino acids from the N-terminal region of human VARS. |
Uniprot ID |
P26640 |
Protein Name |
Valine--tRNA ligase |
Sample Type Confirmation |
VARS is supported by BioGPS gene expression data to be expressed in K562 |
Protein Accession # |
NP_006286.1 |
Gene Symbol |
VARS |
Predicted Species Reactivity |
Human |
Application |
WB, IHC |
Predicted Homology Based on Immunogen Sequence |
Human |
Image 1 | K562
| Western blot analysis of anti-VARS Antibody (N-term) in K562 cell lysates (35ug/lane).VARS (arrow) was detected using the purified Pab (1:60dilution). VARS is supported by BioGPS gene expression data to be expressed in K562 |
| Image 2 | human hepatocarcinoma
| Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with the VARS antibody (N-term), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated. |
|
|